Statistics
Publications
27
Citations
9K
H-Index
20
Active since
1979
Eri Kato is an author at Kyoto University specializing in medicine, cardiovascular disease, and cardiology.
Publications per year
1979–2025
27
27
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
Stephen D. Wiviott, Itamar Raz, Marc P. Bonaca et al. · New England Journal of Medicine · 2018 · 6.3K citations · Full text
Ofri Mosenzon, Stephen D. Wiviott, Avivit Cahn et al. · The Lancet Diabetes & Endocrinology · 2019 · 675 citations · Full text
Medicine, Nephrology, Pharmacology +14
Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus
Eri Kato, Michael G. Silverman, Ofri Mosenzon et al. · Circulation · 2019 · 563 citations
Medicine, Cardiology, Pharmacology +15
1–5 of 27